Metso Outotec expects its sales to improve in Q2 2021, as the distribution of vaccines worldwide may reduce the overall ill-effects of COVID-19 on businesses. Metso’s focus will be on completing the integration between Metso and Outotec after the two entities de-merged in 2020, and to focus on opportunities to recover sales by the end of this year. 


The Finland-based firm’s sales in the first quarter of the year dropped by 2pc to €925mn ($1.1bn) compared to €947mn in Q1 2020. However, its order intakes increased by 2pc to €1.1bn in Q1 2021 from €1bn in the same quarter last year. 


The company’s operating profit in the first three months of the year grew by 33pc to €91mn from €68mn in Q1 2020, while its adjusted EBITDA saw a 20pc rise to €115mn compared to €95mn in the three-month period in 2020. 


$1 = €0.83

Leave a Reply

Your email address will not be published.